Literature DB >> 27873169

Evaluation for the efficacy and safety of the crosser catheter as a CTO crossing device and a flossing device.

Michinao Tan1, Kazushi Urasawa2, Ryoji Koshida2, Takuya Haraguchi2, Shunsuke Kitani2, Yuya Nakagawa2, Yasumi Igarashi2, Katsuhiko Sato2.   

Abstract

The Crosser catheter is a unique device that facilitates antegrade intraluminal recanalization by high-frequency vibration energy and cavitation. We used this device not only as a chronic total occlusion (CTO) crossing device, but also as a flossing device in stenotic lesions and we also evaluated the efficacy of this device when used with both the "Crosser preceding" and the "Guidewire preceding" in CTOs. Complications related to this device were investigated, too. We retrospectively analyzed a total of 90 consecutive patients with peripheral artery disease in the femoropopliteal artery and below-the-knee artery (BTA). Primary technical success was defined as the successful delivery of this device into the distal true lumen. Secondary technical success was defined as successful revascularization. The safety endpoints were events of angiographic complications, including the occurrence of detachment of the metal tip from the shaft, slow flow, dissections, and perforations. Overall primary technical success rate was 93.3% and the secondary technical success rate was 96.7%. Detachment and slow flow occurred 14.4 and 4.4%, respectively, with no occurrences of either dissection or perforation. A predictor of detachment was Proposed Peripheral Arterial Calcium Scoring System (PACSS) grade 4 (OR 14.6; CI 1.26-168.5; P = 0.032). The Crosser catheter is useful not only as a CTO crossing device used with both the "Crosser preceding" and the "Guidewire preceding", but also as a flossing device in stenotic lesions. But we have to pay attention to complications related to the Crosser.

Entities:  

Keywords:  Endovascular intervention; Interventional devices; Peripheral artery disease

Mesh:

Year:  2016        PMID: 27873169     DOI: 10.1007/s12928-016-0444-7

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN: 1868-4297


  1 in total

1.  Endovascular therapy for severely calcified plaque at the superficial femoral artery using myocardial biopsy forceps.

Authors:  Shojiro Hirano; Atsushi Funatsu; Shigeru Nakamura; Takanori Ikeda
Journal:  CVIR Endovasc       Date:  2021-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.